{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:22:22Z","timestamp":1791861742217,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmig.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Minimally Invasive Gynecology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jmig.2021.11.017","type":"journal-article","created":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T02:21:45Z","timestamp":1637806905000},"page":"169-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Cannabidiol for the Management of Endometriosis and Chronic Pelvic Pain"],"prefix":"10.1016","volume":"29","author":[{"given":"Megha","family":"Mistry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0321-8999","authenticated-orcid":false,"given":"Paul","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Katrin","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babu","family":"Karavadra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Lennox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed","family":"Prosser-Snelling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmig.2021.11.017_bib0001","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bpobgyn.2018.01.021","article-title":"From pathogenesis to clinical practice: emerging medical treatments for endometriosis","volume":"51","author":"Clemenza","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.jmig.2021.11.017_bib0002","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000499164","article-title":"Cannabinoids in gynecological diseases","volume":"2","author":"Luschnig","year":"2019","journal-title":"Med Cannabis Cannabinoids"},{"key":"10.1016\/j.jmig.2021.11.017_bib0003","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/molehr\/gas037","article-title":"The molecular connections between the cannabinoid system and endometriosis","volume":"18","author":"Sanchez","year":"2012","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.jmig.2021.11.017_bib0004","article-title":"Decreased expression of cannabinoid receptors in the eutopic and ectopic endometrium of patients with adenomyosis","volume":"2019","author":"Shen","year":"2019","journal-title":"Bio Med Res Int"},{"key":"10.1016\/j.jmig.2021.11.017_bib0005","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1089\/can.2016.0035","article-title":"The clinical significance of endocannabinoids in endometriosis pain management","volume":"2","author":"Bouaziz","year":"2017","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.jmig.2021.11.017_bib0006","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JME-12-0182","article-title":"The endocannabinoid pathway and the female reproductive organs","volume":"50","author":"Di Blasio","year":"2013","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.jmig.2021.11.017_bib0007","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3389\/fphar.2020.00561","article-title":"A balanced approach for cannabidiol use in chronic pain","volume":"11","author":"Argueta","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jmig.2021.11.017_bib0008","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB 1 and CB 2","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jmig.2021.11.017_bib0009","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00418-010-0695-9","article-title":"Histomorphometric evaluation of cannabinoid receptor and anandamide modulating enzyme expression in the human endometrium through the menstrual cycle","volume":"133","author":"Taylor","year":"2010","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.jmig.2021.11.017_bib0010","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/humupd\/dmaa005","article-title":"The fundamental role of the endocannabinoid system in endometrium and placenta: implications in pathophysiological aspects of uterine and pregnancy disorders","volume":"26","author":"Maia","year":"2020","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.jmig.2021.11.017_bib0011","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1016\/j.fertnstert.2010.02.006","article-title":"Endocannabinoid system regulates migration of endometrial stromal cells via cannabinoid receptor 1 through the activation of PI3K and ERK1\/2 pathways","volume":"93","author":"Gentilini","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2021.11.017_bib0012","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10517-019-04456-6","article-title":"Selective action of N-Arachidonoyl dopamine on viability and proliferation of stromal cells from eutopic and ectopic endometrium","volume":"167","author":"Ashba","year":"2019","journal-title":"Bull Exp Biol Med"},{"key":"10.1016\/j.jmig.2021.11.017_bib0013","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1177\/1933719119833483","article-title":"Expression of cannabinoid receptors in myometrium and its correlation with dysmenorrhea in adenomyosis","volume":"26","author":"Shen","year":"2019","journal-title":"Reprod Sci"},{"key":"10.1016\/j.jmig.2021.11.017_bib0014","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1111\/j.1476-5381.2011.01497.x","article-title":"\u0394(9) -Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells","volume":"165","author":"McHugh","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jmig.2021.11.017_bib0015","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.fertnstert.2012.06.009","article-title":"Progesterone-dependent regulation of endometrial cannabinoid receptor type 1 (CB1-R) expression is disrupted in women with endometriosis and in isolated stromal cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)","volume":"98","author":"Resuehr","year":"2012","journal-title":"Fertil Steril"},{"issue":"3 Suppl. 1","key":"10.1016\/j.jmig.2021.11.017_bib0016","first-page":"194A","article-title":"Quantification of endocannabinoids in peritoneal fluid of women with endometriosis - Correlation with active disease","volume":"18","author":"Marczylo","year":"2011","journal-title":"Reprod Sci"},{"key":"10.1016\/j.jmig.2021.11.017_bib0017","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejogrb.2019.11.012","article-title":"The role of the endocannabinoid system in aetiopathogenesis of endometriosis: A potential therapeutic target","volume":"244","author":"Tanaka","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jmig.2021.11.017_bib0018","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1177\/1933719116630414","article-title":"Elevated systemic levels of endocannabinoids and related mediators across the menstrual cycle in women with endometriosis","volume":"23","author":"Sanchez","year":"2016","journal-title":"Reprod Sci"},{"key":"10.1016\/j.jmig.2021.11.017_bib0019","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.2353\/ajpath.2010.100375","article-title":"Antiproliferative effects of cannabinoid agonists on deep infiltrating endometriosis","volume":"177","author":"Leconte","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jmig.2021.11.017_bib0020","series-title":"Presented at 2nd European Congress on Endometriosis","article-title":"Alterations in the expression of CB1 seem to be involved in the chronic inflammation in endometriosis","author":"Barcena De Arellano","year":"2013"},{"key":"10.1016\/j.jmig.2021.11.017_bib0021","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/j.pain.0000000000002333","article-title":"Association of endocannabinoids with pain in endometriosis","volume":"163","author":"Andrieu","year":"2022","journal-title":"Pain"},{"key":"10.1016\/j.jmig.2021.11.017_bib0022","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1093\/humrep\/dei135","article-title":"ESHRE guideline for the diagnosis and treatment of endometriosis","volume":"20","author":"Kennedy","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jmig.2021.11.017_bib0023","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/humrep\/det457","article-title":"ESHRE guideline: Management of women with endometriosis","volume":"29","author":"Dunselman","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jmig.2021.11.017_bib0024","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.acthis.2017.05.005","article-title":"Endocannabinoids modulate apoptosis in endometriosis and adenomyosis","volume":"119","author":"Bilgic","year":"2017","journal-title":"Acta Histochem"},{"key":"10.1016\/j.jmig.2021.11.017_bib0025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.tox.2018.11.006","article-title":"Synthetic cannabinoids and endometrial stromal cell fate: dissimilar effects of JWH-122, UR-144 and WIN55,212-2","volume":"413","author":"Fonseca","year":"2019","journal-title":"Toxicology"},{"key":"10.1016\/j.jmig.2021.11.017_bib0026","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.brainres.2017.03.016","article-title":"Cannabinoid receptor 1 contributes to sprouted innervation in endometrial ectopic growth through mitogen-activated protein kinase activation","volume":"1663","author":"Han","year":"2017","journal-title":"Brain Res"},{"issue":"3 Suppl. 1","key":"10.1016\/j.jmig.2021.11.017_bib0027","first-page":"99A","article-title":"Targeting of the cannabinoid signalling pathways affect endometrial cell survival, proliferation and inflammation in a mouse model of endometriosis","volume":"20","author":"Sanchez","year":"2013","journal-title":"Reprod Sci"},{"key":"10.1016\/j.jmig.2021.11.017_bib0028","doi-asserted-by":"crossref","first-page":"e50356","DOI":"10.7554\/eLife.50356","article-title":"Disease-modifying effects of natural \u03949-tetrahydrocannabinol in endometriosis-associated pain","volume":"9","author":"Escudero-Lara","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.jmig.2021.11.017_bib0029","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.pain.2010.08.037","article-title":"Endocannabinoid involvement in endometriosis","volume":"151","author":"Dmitrieva","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.jmig.2021.11.017_bib0030","first-page":"175","article-title":"The cannabinoid receptor CB1 contributes to the development of ectopic lesions in a mouse model of endometriosis","volume":"32","author":"Sanchez","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jmig.2021.11.017_bib0031","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1016\/j.fertnstert.2015.07.209","article-title":"Endocannabinoid system modulation in women affected by unilateral endometrioma","volume":"104","author":"Notarstefano","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2021.11.017_bib0032","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/humupd\/dmr030","article-title":"The translational challenge in the development of new and effective therapies for endometriosis: a review of confidence from published preclinical efficacy studies","volume":"17","author":"Pullen","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.jmig.2021.11.017_bib0033","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.jpain.2017.12.182","article-title":"The influence of chronic WIN 55, 212\u20132 treatment on vaginal hyperalgesia, VEGF, and NGF in a rat model of endometriosis","volume":"19","author":"McAllister","year":"2018","journal-title":"J Pain"},{"key":"10.1016\/j.jmig.2021.11.017_bib0034","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jogc.2019.08.033","article-title":"Cannabis use, a self-management strategy among Australian women with endometriosis: results from a national online survey","volume":"42","author":"Sinclair","year":"2020","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jmig.2021.11.017_bib0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12906-019-2431-x","article-title":"Self-management strategies amongst Australian women with endometriosis: a national online survey","volume":"19","author":"Armour","year":"2019","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/j.jmig.2021.11.017_bib0036","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/j.jmig.2019.09.682","article-title":"Self-reported efficacy of cannabis for endometriosis pain","volume":"26","author":"Reinert","year":"2019","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.jmig.2021.11.017_bib0037","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000511664","article-title":"Optimizing women's health with medical cannabis. Abstracts - 5th International Medical Cannabis Conference (CannX 2020), Virtual, October 26-28, 2020","volume":"3","author":"Thirlwell","year":"2020","journal-title":"Med Cannabis Cannabinoids"},{"key":"10.1016\/j.jmig.2021.11.017_bib0038","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hoaa028","article-title":"Self-management strategies to consider to combat endometriosis symptoms during the COVID-19 pandemic","volume":"2020","author":"Leonardi","year":"2020","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.jmig.2021.11.017_bib0039","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1089\/jwh.2020.8668","article-title":"Illicit cannabis usage as a management strategy in New Zealand women with endometriosis: an online survey","volume":"30","author":"Armour","year":"2021","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.jmig.2021.11.017_bib0040","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1089\/jwh.2020.8737","article-title":"Use of cannabis for self-management of chronic pelvic pain","volume":"30","author":"Carrubba","year":"2021","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.jmig.2021.11.017_bib0041","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1089\/jwh.2020.8491","article-title":"Willingness to use cannabis for gynecological conditions: A national survey","volume":"30","author":"Han","year":"2021","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.jmig.2021.11.017_bib0042","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/humupd\/dmaa039","article-title":"Plants as source of new therapies for endometriosis: a review of preclinical and clinical studies","volume":"27","author":"Meresman","year":"2021","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.jmig.2021.11.017_bib0043","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/22840265211011277","article-title":"Cannabinoids and chronic pelvic pain in women: focus on endometriosis","volume":"13","author":"Marcu","year":"2021","journal-title":"J Endometriosis Pelvic Pain Disord"},{"key":"10.1016\/j.jmig.2021.11.017_bib0044","first-page":"125","article-title":"Micronized palmitoylethanolamide\/trans-polydatin treatment of endometriosis-related pain: a meta-analysis","volume":"53","author":"Indraccolo","year":"2017","journal-title":"Ann Ist Super Sanita"},{"key":"10.1016\/j.jmig.2021.11.017_bib0045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejogrb.2011.04.011","article-title":"Effectiveness of the association micronized N-Palmitoylethanolamine (PEA)\u2013transpolydatin in the treatment of chronic pelvic pain related to endometriosis after laparoscopic assessment: a pilot study","volume":"158","author":"Cobellis","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jmig.2021.11.017_bib0046","unstructured":"Chu A, Watts H. Cannabidiol and management of endometriosis pain.Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04527003. Accessed October 7, 2021."},{"key":"10.1016\/j.jmig.2021.11.017_bib0047","unstructured":"Circular 001\/2020: Epidyolex scheduling, (SI) 2020 No. 559. Available at:https:\/\/www.gov.uk\/government\/publications\/circular-0012020-epidyolex-scheduling-si-2020-no-559\/circular-0012020-epidyolex-scheduling-si-2020-no-559. Accessed September 27, 2020."},{"key":"10.1016\/j.jmig.2021.11.017_bib0048","unstructured":"NICE Guideline Updates Team (UK). Cannabis-Based Medicinal Products. London: National Institute for Health and Care Excellence (UK), 2019. Available at: https:\/\/www.nice.org.uk\/guidance\/ng144. Accessed September 27, 2020."},{"key":"10.1016\/j.jmig.2021.11.017_bib0049","unstructured":"Cannabis-based medicinal products. NICE Guideline, No. 144.Available at: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK552187\/. Accessed September 27, 2020."},{"key":"10.1016\/j.jmig.2021.11.017_bib0050","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bjae.2020.05.002","article-title":"Cannabinoids in chronic non-cancer pain medicine: moving from the bench to the bedside","volume":"20","author":"Meng","year":"2020","journal-title":"BJA Educ"},{"key":"10.1016\/j.jmig.2021.11.017_bib0051","article-title":"Cannabis-based medicines for chronic neuropathic pain in adults","volume":"3","author":"M\u00fccke","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jmig.2021.11.017_bib0052","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s40265-016-0687-8","article-title":"As-Sanie S. Pharmacological management of chronic pelvic pain in women","volume":"77","author":"Carey","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.jmig.2021.11.017_bib0053","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB 1 and CB 2","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol Rev"}],"container-title":["Journal of Minimally Invasive Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553465021012863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553465021012863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:42:30Z","timestamp":1761558150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553465021012863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1553465021012863"],"URL":"https:\/\/doi.org\/10.1016\/j.jmig.2021.11.017","relation":{},"ISSN":["1553-4650"],"issn-type":[{"value":"1553-4650","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabidiol for the Management of Endometriosis and Chronic Pelvic Pain","name":"articletitle","label":"Article Title"},{"value":"Journal of Minimally Invasive Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmig.2021.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 AAGL. All rights reserved.","name":"copyright","label":"Copyright"}]}}